"Fumarates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds based on fumaric acid.
| Descriptor ID |
D005650
|
| MeSH Number(s) |
D02.241.081.337.302
|
| Concept/Terms |
Fumaric Acid Esters- Fumaric Acid Esters
- Acid Esters, Fumaric
- Esters, Fumaric Acid
- Fumarate Esters
- Esters, Fumarate
|
Below are MeSH descriptors whose meaning is more general than "Fumarates".
Below are MeSH descriptors whose meaning is more specific than "Fumarates".
This graph shows the total number of publications written about "Fumarates" by people in this website by year, and whether "Fumarates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 2 | 1 | 3 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2021 | 0 | 2 | 2 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fumarates" by people in Profiles.
-
Edosuyi O, Igbe I, Oyekan A. Fumarate and its downstream signalling pathways in the cardiorenal system: Recent insights and novel expositions in the etiology of hypertension. Eur J Pharmacol. 2023 Dec 15; 961:176186.
-
Borza DB. Fumarate in membranous nephropathy: more questions than answers. Kidney Int. 2021 09; 100(3):707.
-
Edosuyi O, Choi M, Igbe I, Oyekan A. Fumarate exerted an antihypertensive effect and reduced kidney injury molecule (KIM)-1 expression in deoxycorticosterone acetate-salt hypertension. Clin Exp Hypertens. 2021 Aug 18; 43(6):555-564.
-
De Mello W. Intracellular renin increases the inward calcium current in smooth muscle cells of mesenteric artery of SHR. Implications for hypertension and vascular remodeling. Peptides. 2016 10; 84:36-43.
-
Lu Y, Mantha SN, Crowder DC, Chinchilla S, Shah KN, Yun YH, Wicker RB, Choi JW. Microstereolithography and characterization of poly(propylene fumarate)-based drug-loaded microneedle arrays. Biofabrication. 2015 Sep 29; 7(4):045001.
-
Zhang J, Li C, Zhang X, Huo S, Jin S, An FF, Wang X, Xue X, Okeke CI, Duan G, Guo F, Zhang X, Hao J, Wang PC, Zhang J, Liang XJ. In vivo tumor-targeted dual-modal fluorescence/CT imaging using a nanoprobe co-loaded with an aggregation-induced emission dye and gold nanoparticles. Biomaterials. 2015 Feb; 42:103-11.
-
Hoffmann P, Beckman D, McLean LA, Yan JH. Aliskiren toxicity in juvenile rats is determined by ontogenic regulation of intestinal P-glycoprotein expression. Toxicol Appl Pharmacol. 2014 Feb 15; 275(1):36-43.
-
De Mello WC. Spironolactone enhances the beneficial effect of aliskiren on cardiac structural and electrical remodeling in TGR(mRen2)27 rats. J Renin Angiotensin Aldosterone Syst. 2015 Sep; 16(3):488-94.
-
De Mello W, Rivera M, Rabell A, Gerena Y. Aliskiren, at low doses, reduces the electrical remodeling in the heart of the TGR(mRen2)27 rat independently of blood pressure. J Renin Angiotensin Aldosterone Syst. 2013 Mar; 14(1):23-33.
-
Crespo MJ, Cangiano JL, Altieri PI, Escobales N. Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters. J Cardiovasc Pharmacol. 2012 Jun; 59(6):547-52.